RFTech Subsidiary RFBio Undergoes Change in Control via Third-Party Allotment and Block Sale; RFTech Stake Drops to 18.37%
RFBio, a subsidiary of RFTech, is transferring control to AccessBio Incorporation via a third-party allotment of 3,369,763 new shares (at 10,980 won each) and a block sale of 910,747 existing shares by RFTech (at 21,960 won each)
Purpose: to normalize operations through raising working capital and repaying debt; RFBio has debt of about 20 billion won
RFTech's stake in RFBio drops from 96.22% to 18.37%, potentially leading to deconsolidation; RFTech receives about 20 billion won from the block sale but loses future earnings from RFBio; new shares issued at a 50% discount to the sale price, raising dilution concerns for existing shareholders
Proceeds from the new shares (approx. 37 billion won) will be used for debt repayment (20 billion won) and operating expenses (17 billion won) including personnel costs and new business development
[AI Summary]While RFTech gains 20 billion won in cash, the loss of control over a major subsidiary negatively impacts consolidated financial statements; the new share issuance at a steep discount is unfavorable to existing shareholders, and despite the premium on the block sale, dilution risk remains significant
KOSDAQ Filing Information
Filing: [Correction of Description] Decision on Paid-in Capital Increase (Major Management Matters of Subsidiary)